Literature DB >> 19057975

Limiting exposure to medical malpractice claims and defamatory cyber postings via patient contracts.

Michael Sacopulos1, Jeffrey J Segal.   

Abstract

The documents patients sign on admission to a medical practice can constitute a legal contract. Medical practices around the country are attempting to use these documents as a prospective defense against medical malpractice claims. Protective contractual provisions are often attacked on grounds that they are legally void as a result of unconscionability. Widespread use of arbitration clauses have been met with mixed success. Arbitration clauses that limit damages available in medical negligence cases have been stricken in some states as having provisions that impose excessive entry costs on a patient starting the arbitration process. Other provisions relating to prequalification requirements for expert witnesses are now being used with increasing frequency. Clauses have even been placed in patient contracts that address cyber postings of adverse claims against physicians. Prospective patient contracts may be an effective means to limit exposure to medical malpractice lawsuits and to minimize defamatory cyber postings.

Entities:  

Mesh:

Year:  2008        PMID: 19057975      PMCID: PMC2628519          DOI: 10.1007/s11999-008-0619-3

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  1 in total

1.  The jury is out: pre-dispute binding arbitration agreements for medical malpractice claims: law, ethics, and prudence.

Authors:  Kenneth A DeVille
Journal:  J Leg Med       Date:  2007 Jul-Sep
  1 in total
  2 in total

1.  Contracts with patients in clinical practice.

Authors:  Michael L Volk; Sarah R Lieber; Scott Y Kim; Peter A Ubel; Carl E Schneider
Journal:  Lancet       Date:  2011-04-14       Impact factor: 79.321

2.  Power and control: contracts and the patient-physician relationship.

Authors:  S R Lieber; S Y Kim; M L Volk
Journal:  Int J Clin Pract       Date:  2011-12       Impact factor: 2.503

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.